


Ask a doctor about a prescription for VARDENAFIL KRKA 20 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Vardenafil Krka 20 mg Film-Coated Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet:
This medicine contains vardenafil, which belongs to a group of medicines called phosphodiesterase 5 inhibitors, used to treat erectile dysfunction in adult men, a condition which means that the man cannot achieve or maintain an erection.
At least one in ten men has, at some time, problems achieving or maintaining an erection. This can be due to either physical or psychological causes, or a combination of both. Regardless of the cause, muscle and blood vessel changes result in not enough blood entering the penis to achieve and maintain an erection.
Vardenafil will only work when you are sexually stimulated. This medicine reduces the action of a natural chemical in your body which is stopping an erection. Vardenafil allows an erection to last long enough for you to have successful sex.
Do not take Vardenafil Krka
Warnings and precautions
Consult your doctor or pharmacist before taking this medicine.
Be cautious when taking Vardenafil Krka
Children and adolescents
Vardenafil Krka should not be used in children or adolescents under 18 years of age.
Other medicines and Vardenafil Krka
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription.
Some medicines may cause problems, especially:
Do not take vardenafil film-coated tablets in combination with other medicines for erectile dysfunction, including vardenafil orodispersible tablets.
Taking Vardenafil Krka with food, drinks and alcohol
You can take vardenafil with or without food, but it is best not to take it after a large or high-fat meal, as this may delay the effect.
Do not drink grapefruit juice when taking vardenafil, as it may affect the efficacy of the medicine.
Drinking alcohol may impair your ability to get an erection.
Pregnancy and breastfeeding
Vardenafil Krka should not be used in women.
Driving and using machines
Vardenafil may cause dizziness or affect your vision. Do not drive or operate machinery if you feel dizzy or have any problems with your vision after taking vardenafil.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
The recommended dose is 10 mg.
Take a vardenafil tablet 25-60 minutes before you plan to have sex. With sexual stimulation, you may achieve an erection from 25 minutes up to 4-5 hours after taking vardenafil.
Swallow the tablet with a glass of water.
Do not take Vardenafil Krka film-coated tabletswith any other formulation of vardenafil.
Do not take Vardenafil Krkamore than once a day.
If you think that the effect of vardenafil is too strong or too weak, talk to your doctor.
If you take more Vardenafil Krka than you should
Taking too many vardenafil tablets may cause more side effects. In case of overdose or accidental intake, consult your doctor or pharmacist immediately or call the National Poison Centre, phone 91 562 04 20, indicating the medicine and the amount taken.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Most of the side effects are mild or moderate.
Some patients have experienced a sudden loss of vision in one or both eyes, distorted vision, blurred vision, or loss of vision, temporary or permanent, in one or both eyes. Stop taking vardenafil and contact your doctor immediately.
There have been reports of sudden death, rapid or irregular heartbeat, heart attack, chest pain, and stroke in men taking vardenafil. Most of these men had pre-existing heart problems.
There have also been reports of sudden decrease or loss of hearing.
The likelihood of experiencing a side effect is described in the following categories:
Very common side effects:may affect more than 1 in 10 people:
Common side effects:may affect up to 1 in 10 people:
Uncommon side effects:may affect up to 1 in 100 people:
Rare side effects:may affect up to 1 in 1,000 people:
Very rare or unknown frequency side effects:may affect less than 1 in 10,000 people or the frequency cannot be estimated from the available data:
Reporting of side effects
If you experience any side effects, talk to your doctor, even if they are not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Agency (AEMPS) at www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging after "EXP". The expiry date refers to the last day of the month.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help to protect the environment.
Composition of Vardenafil Krka
Appearance and packaging of the product
20 mg film-coated tablets: the film-coated tablets are orange-brown, round, biconvex, with beveled edges, scored on one side and engraved with a "20" on the other side, diameter 10 mm. The tablet can be divided into equal doses.
Vardenafil Krka is available in packs containing:
Not all pack sizes may be marketed.
Marketing authorisation holder
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Manufacturer
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany
For further information about this medicine, contact the local representative of the marketing authorisation holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain
This medicinal product is authorised in the Member States of the European Economic Area under the following names:
Member State | Marketing authorisation holder |
Sweden | Vardenafil Krka 20 mg |
Austria | Vardenafil Krka 20 mg Filmtabletten |
Belgium | Vardenafil Krka 20 mg filmomhulde tabletten |
Denmark | Vardenafil Krka 20 mg filmovertrukne tabletter |
France | Vardenafil Krka 20 mg |
Finland | Vardenafil Krka 20 mg kalvopäällysteiset tabletit |
Ireland | Vardenafil Krka 20 mg film-coated tablets |
Italy | Vardenafil Krka |
Norway | Vardenafil Krka |
Portugal | Vardenafil Krka |
Spain | Vardenafilo Krka 20 mg comprimidos recubiertos con película |
United Kingdom | Vardenafil Krka 20 mg film-coated tablets |
Date of last revision of this leaflet:May 2025
Detailed information on this medicine is available on the website of the Spanish Medicines Agency (AEMPS) http://www.aemps.gob.es/.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for VARDENAFIL KRKA 20 mg FILM-COATED TABLETS – subject to medical assessment and local rules.